Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-?1
- 1 September 2003
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 129 (9) , 536-542
- https://doi.org/10.1007/s00432-003-0460-8
Abstract
In the liver, transforming growth factor beta-1 (TGF-β1) constitutes a major negative growth regulating factor involved in the control of cell numbers; failure of this control mechanism has been associated with the development of liver cancer. Since no reports on the in vivo effects of exogenously administered TGF-β1 on apoptosis in liver tumors have been published yet, we studied hepatocyte sensitivity to the proapoptotic action of TGF-β1 in stages of chemically induced mouse liver carcinogenesis. Mouse liver carcinogenesis was initiated by a single dose of N-nitrosodiethylamine (NDEA, 90 mg/kg b.w., i.p.) to 5-week-old B6C3F1 mice. After 2 weeks, mice received either standard diet or a diet containing phenobarbital (PB, 90 mg/kg b.w) for 85 weeks. Four hours before being killed mice received a single dose of TGF-β1 (56 μg or 200 μg TGF-β1/kg of b.w., injected into the tail vein). Quantitative histological analysis of mitosis and apoptosis in normal liver tissue (NL), putative preneoplastic foci (PPF), hepatocellular adenoma (HCA), and hepatocellular carcinoma (HCC) was performed on H&E-stained liver sections. In NDEA and NDEA + PB-treated mice, NL exhibited a very low incidence of apoptosis and mitosis, which increased in HCA and HCC. In the lesions apoptoses ranged between 0.03 and 0.6%. Two hundred micrograms of TGF-β1/kg stimulated apoptoses in NL as well as in neoplastic lesions (significant increase in NL, HCA, and HCC); the most pronounced proapoptotic action of TGF-ß1 was observed in lesions of NDEA+PB pretreated mice (about 1.7%). Fifty-six μg TGF-β1/kg had no detectable effect on apoptosis. These observations indicate that during chemically induced liver carcinogenesis in B6C3F1 mice basal rates of apoptoses in adenoma and carcinoma are higher than in normal liver and can be further increased by a proapoptotic cytokine.Keywords
This publication has 57 references indexed in Scilit:
- Liver regenerationJournal of Hepatology, 2000
- Apoptotic Response to TGF-$beta; in Fetal Hepatocytes Depends upon Their State of DifferentiationExperimental Cell Research, 1999
- Perturbation of the Mitosis/Apoptosis Balance: A Fundamental Mechanism in Toxicology,Fundamental and Applied Toxicology, 1997
- TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytesJournal of Hepatology, 1997
- Variation of immunocytochemical expression of transforming growth factor (TGF)-β in hepatocytes in culture and liver slicesCell and tissue research, 1996
- Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbitalCarcinogenesis: Integrative Cancer Research, 1994
- Transforming growth factor-β receptors type I, II and III in phenobarbital-promoted rat liver tumorsCarcinogenesis: Integrative Cancer Research, 1994
- Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.Proceedings of the National Academy of Sciences, 1988
- Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasiaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1986
- Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary cultureBiochemical and Biophysical Research Communications, 1985